Literature DB >> 18560277

Dexmedetomidine use in critical care.

Simon W Lam1, Earnest Alexander.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560277     DOI: 10.1097/01.AACN.0000318109.06073.35

Source DB:  PubMed          Journal:  AACN Adv Crit Care        ISSN: 1559-7768


× No keyword cloud information.
  5 in total

1.  Effectiveness of nebulized dexmedetomidine for treatment of post-dural puncture headache in parturients undergoing elective cesarean section under spinal anesthesia: a randomized controlled study.

Authors:  Sherif M S Mowafy; Shereen E Abd Ellatif
Journal:  J Anesth       Date:  2021-05-16       Impact factor: 2.078

2.  Dexmedetomidine suppresses bupivacaine-induced parthanatos in human SH-SY5Y cells via the miR-7-5p/PARP1 axis-mediated ROS.

Authors:  Ting Zheng; Chunying Zheng; Fei Gao; Fengyi Huang; Bin Hu; Xiaochun Zheng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-09-28       Impact factor: 3.000

3.  Dexmedetomidine Attenuates Bilirubin-Induced Lung Alveolar Epithelial Cell Death In Vitro and In Vivo.

Authors:  Jian Cui; Hailin Zhao; Bin Yi; Jing Zeng; Kaizhi Lu; Daqing Ma
Journal:  Crit Care Med       Date:  2015-09       Impact factor: 7.598

4.  Effect of dexmedetomidine and midazolam for flexible fiberoptic bronchoscopy in intensive care unit patients: A retrospective study.

Authors:  Yang Gao; Kai Kang; Haitao Liu; Liu Jia; Rong Tang; Xing Zhang; Hongliang Wang; Kaijiang Yu
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

5.  Antioxidant effects of dexmedetomidine against hydrogen peroxide-induced DNA damage in vitro by alkaline Comet assay

Authors:  Mustafa Sirri Kotanoğlu; Ela Kadioğlu; Esra Emerce; Çetin Kaymak; Ayşe Özcan; Hülya Başar
Journal:  Turk J Med Sci       Date:  2020-08-26       Impact factor: 0.973

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.